Qilu Pharmaceutical Competitors and Similar CompaniesClear all
Hetero's competitors and similar companies include WuXi AppTec and Catalent.
 Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | |
Founding Date | Founding Date 1993 | Founding Date 2000 | Founding Date 2007 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more |
Employees | Employees 7,0042% increase | Employees 39,414 | Employees 12,6955% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $3.4b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit ¥21.3b (FY, 2025) | Gross profit $953m (FY, 2024) |
Net income | Net income N/A | Net income ¥19.3b (FY, 2025) | Net income ($1b) (FY, 2024) |
Operating ⚠ | |||
Countries | Countries 126 (Jan, 2021) | Countries N/A | Countries 80 (FY, 2023) |
Products | Products 200 (Jan, 2021) | Products N/A | Products 8 k (FY, 2023) |
Scientists and Researchers | Scientists and Researchers 1 k (Jan, 2021) | Scientists and Researchers 38 k (H1, 2023) | Scientists and Researchers N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised $ 650m |
For sources of this data, please see the company profile
View Company Profiles
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company